ArticleBlood advances2021

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma.

C Perry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.